Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | - | 5.0 |
Min SIP Amount | ₹500 | ₹1000 |
Expense Ratio | 1.03 | 0.13 |
NAV | ₹15.49 | ₹32.08 |
Fund Started | 04 Mar 2022 | 19 Jun 2018 |
Fund Size | ₹100.37 Cr | ₹2165.02 Cr |
Exit Load | Exit load of 1% if redeemed within 15 days. | - |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 18.45% | 39.13% |
3 Year | - | 33.19% |
5 Year | - | 25.25% |
1 Year
3 Year
5 Year
Equity | 100.02% | 0.00% |
Cash | -0.02% | 100.00% |
Equity
Cash
Top 10 Holdings |
| - |
Top 10 Holdings
Name | Assets |
---|---|
Sun Pharmaceutical Industries Ltd. | 4.03% |
ICICI Bank Ltd. | 3.92% |
Britannia Industries Ltd. | 3.85% |
ITC Ltd. | 3.70% |
HDFC Bank Ltd. | 3.62% |
Bharti Airtel Ltd. | 3.56% |
Asian Paints Ltd. | 3.56% |
Hindustan Unilever Ltd. | 3.54% |
Dr. Reddy's Laboratories Ltd. | 3.50% |
Nestle India Ltd. | 3.49% |
Name | Swapnil P Mayekar | Kayzad Eghlim |
Start Date | 14 Jul 2022 | 03 Dec 2021 |
Name
Start Date
Description | The investment objective of the scheme is to provide returns that, before expenses, correspond to the total returns of the securities as represented by S&P BSE Low Volatility Total Return Index, subject to tracking error. | The scheme seeks to generate returns by investing in units of BHARAT 22 ETF. |
Launch Date | 04 Mar 2022 | 19 Jun 2018 |
Description
Launch Date